Inactivation of the ubiquitin conjugating enzyme UBE2Q2 causes a prophase arrest and enhanced apoptosis in response to microtubule inhibiting agents

Oncogene

Volumn 26, Issue 45, 2007, Pages 6509-6517

  Banerjee, S ^a   Brooks, W S ^b   Crawford, D F ^a,b,c,d  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Antephase; Apoptosis; Checkpoint; Microtubule inhibiting agents (MIAs); Mitosis; UBE2Q2

Indexed keywords

CASPASE; CYSTEINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; UBE2Q2 PROTEIN; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL VIABILITY; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; ENZYME ACTIVE SITE; ENZYME DEGRADATION; ENZYME INACTIVATION; FEMALE; HUMAN; HUMAN CELL; MICROTUBULE; MITOSIS; MITOSIS INHIBITION; MITOSIS RATE; PRIORITY JOURNAL; PROPHASE; PROTEIN BINDING;

APOPTOSIS; BINDING SITES; CELL CYCLE; CYTOSKELETAL PROTEINS; HELA CELLS; HUMANS; MITOSIS; POLY(ADP-RIBOSE) POLYMERASES; PROPHASE; TUBULIN MODULATORS; UBIQUITIN; UBIQUITIN-CONJUGATING ENZYMES; VINCRISTINE;

EUKARYOTA;

EID: 34948826435     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210471     Document Type: Article

References (40)

1. Aristarkhov A, Eytan E, Moghe A, Admon A, Hershko A, Ruderman JV. (1996). E2-C, a cyclin-selective ubiquitin carrier protein required for the destruction of mitotic cyclins. Proc Natl Acad Sci USA 93: 4294-4299.
2. Baker DJ, Chen J, van Deursen JM. (2005). The mitotic checkpoint in cancer and aging: what have mice taught us? Curr Opin Cell Biol 17: 583-589.
3. Banerjee A, Deshaies RJ, Chau V. (1995). Characterization of a dominant negative mutant of the cell cycle ubiquitin-conjugating enzyme Cdc34. J Biol Chem 270: 26209-26215.
4. Bhalla KN. (2003). Microtubule-targeted anticancer agents and apoptosis. Oncogene 22: 9075-9086.
5. Chen C, Okayama H. (1987). High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7: 27 45-2752.
6. Corn PG, Summers MK, Fogt F, Virmani AK, Gazdar AF, Halazonetis TD et al. (2003). Frequent hypermethylation of the 5′ CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer. Carcinogenesis 24: 47-51.
7. Crawford DF, Piwnica-Worms H. (2001). The G(2) DNA damage checkpoint delays expression of genes encoding mitotic regulators. J Biol Chem 276: 37166-37177.
8. Gorbsky GJ. (2001). The mitotic spindle checkpoint. Curr Biol 11: R1001-R1004.
9. Gu H, Roizman B. (2003). The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin- conjugating enzyme UbcH5a. Proc Natl Acad Sci USA 100: 8963-8968.
10. Huang Y, Fang Y, Wu J, Dziadyk JM, Zhu X, Sui M et al. (2004). Regulation of Vinca alkaloid-induced apoptosis by NF-kappaB/IkappaB pathway in human tumor cells. Mol Cancer Ther 3: 271-277.
11. Koh DW, Dawson TM, Dawson VL. (2005). Mediation of cell death by poly(ADP-ribose) polymerase-1. Pharmacol Res 52: 5-14.
12. Kung AL, Sherwood SW, Schimke RT. (1990). Cell line-specific differences in the control of cell cycle progression in the absence of mitosis. Proc Natl Acad Sci USA 87: 95 53-9557.
13. Lew DJ, Burke DJ. (2003). The spindle assembly and spindle position checkpoints. Annu Rev Genet 37: 251-282.
14. Li L, Aggarwal BB, Shishodia S, Abbruzzese J, Kurzrock R. (2004). Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer 101: 2351-2362.
15. Li YP, Lecker SH, Chen Y, Waddell ID, Goldberg AL, Reid MB. (2003). TNF-alpha increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J 17: 1048-1057.
16. Liu Q, Shang F, Whitcomb E, Guo W, Li W, Taylor A. (2006). Ubiquitin-conjugating enzyme 3 delays human lens epithelial cells in metaphase. Invest Ophthalmol Vis Sci 47: 1302-130 9.
17. Matsusaka T, Pines J. (2004). Chfr acts with the p38 stress kinases to block entry to mitosis in mammalian cells. J Cell Biol 166: 507-516.
18. Melner MH, Ducharme NA, Brash AR, Winfrey VP, Olson GE. (2004). Differential expression of genes in the endometrium at implantation: upregulation of a novel member of the E2 class of ubiquitin-conjugating enzymes. Biol Reprod 70: 406-414.
19. Melner MH, Haas AL, Klein JM, Brash AR, Boeglin WE, Nagdas SK et al. (2006). Demonstration of ubiquitin thiolester formation of UBE2Q2 (UBCi), a novel ubiquitin conjugating enzyme with implantation site-specific expression. Biol Reprod 75: 395-406.
20. Mizuno K, Osada H, Konishi H, Tatematsu Y, Yatabe Y, Mitsudomi T et al. (2002). Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers. Oncogene 21: 2328-2333.
21. Mollinedo F, Gajate C. (2003). Microtubules, microtubule-interfering agents and apoptosis. Apoptosis 8: 413-450.
22. Musacchio A, Hardwick KG. (2002). The spindle checkpoint: structural insights into dynamic signalling. Nat Rev Mol Cell Biol 3: 731-741.
23. Pallardy M, Biola A, Lebrec H, Breard J. (1999). Assessment of apoptosis in xenobiotic-induced immunotoxicity. Methods 19: 36-47.
24. Pati D, Meistrich ML, Plon SE. (1999). Human Cdc34 and Rad6B ubiquitin-conjugating enzymes target repressors of cyclic AMP-induced transcription for proteolysis. Mol Cell Biol 19: 5001-5013.
25. Pinkerton CR, McDermott B, Philip T, Biron P, Ardiet C, Vandenberg H et al. (1988). Continuous vincristine infusion as part of a high dose chemoradiotherapy regimen: drug kinetics and toxicity. Cancer Chemother Pharmacol 22: 271-274.
26. Pray TR, Parlati F, Huang J, Wong BR, Payan DG, Bennett MK et al. (2002). Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. Drug Resist Updat 5: 249-258.
27. Rieder CL, Cole R. (2000). Microtubule disassembly delays the G2-M transition in vertebrates. Curr Biol 10: 1067-1070.
28. Rieder CL, Palazzo RE. (1992). Colcemid and the mitotic cycle. J Cell Sci 102(Part 3): 387-392.
29. Rieder CL, Schultz A, Cole R, Sluder G. (1994). Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle. J Cell Biol 127: 1301-1310.
30. Schulze E, Altmann ME, Adham IM, Schulze B, Frode S, Engel W. (2003). The maintenance of neuromuscular function requires UBC-25 in Caenorhabditis elegans. Biochem Biophys Res Commun 305: 691-699.
31. Scolnick DM, Halazonetis TD. (2000). Chfr defines a mitotic stress checkpoint that delays entry into metaphase. Nature 406: 430-435.
32. Seghatoleslam A, Zambrano A, Millon R, Ganguli G, Argentini M, Cromer A et al. (2006). Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours. Biochem Biophys Res Commun 339: 422-429.
33. Skerra A, Schmidt TG. (1999). Applications of a peptide ligand for streptavidin: the strep-tag. Biomol Eng 16: 79-86.
34. Tashiro K, Pando MP, Kanegae Y, Wamsley PM, Inoue S, Verma IM. (1997). Direct involvement of the ubiquitin-conjugating enzyme Ubc9/Hus5 in the degradation of IkappaBalpha. Proc Natl Acad Sci USA 94: 7862-7867.
35. Townsley FM, Aristarkhov A, Beck S, Hershko A, Ruderman JV. (1997). Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase. Proc Natl Acad Sci USA 94: 2362-2367.
36. Toyota M, Sasaki Y, Satoh A, Ogi K, Kikuchi T, Suzuki H et al. (2003). Epigenetic inactivation of CHFR in human tumors. Proc Natl Acad Sci USA 100: 7818-7823.
37. Vodermaier HC. (2004). APC/C and SCF: controlling each other and the cell cycle. Curr Biol 14: R787-R796.
38. Weissman AM. (2001). Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2: 169-178.
39. Xu B, Kim S, Kastan MB. (2001). Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation. Mol Cell Biol 21: 3445-3450.
40. Zhang YW, Otterness DM, Chiang GG, Xie W, Liu YC, Mercurio F et al. (2005). Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol Cell 19: 607-618.